173 related articles for article (PubMed ID: 10929259)
1. [++UKPDS Study. Metformin in obese patients with Type 2 diabetes (UKPDS 340].
Janka HU
Internist (Berl); 2000 Jul; 41(7):688-9. PubMed ID: 10929259
[No Abstract] [Full Text] [Related]
2. Applying some UK Prospective Diabetes Study results to Switzerland: the cost-effectiveness of intensive glycaemic control with metformin versus conventional control in overweight patients with type-2 diabetes.
Palmer AJ; Sendi PP; Spinas GA
Schweiz Med Wochenschr; 2000 Jul; 130(27-28):1034-40. PubMed ID: 10953853
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
Clarke P; Gray A; Adler A; Stevens R; Raikou M; Cull C; Stratton I; Holman R;
Diabetologia; 2001 Mar; 44(3):298-304. PubMed ID: 11317659
[TBL] [Abstract][Full Text] [Related]
4. Improving survival with metformin: the evidence base today.
Scarpello JH
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S36-43. PubMed ID: 14502099
[TBL] [Abstract][Full Text] [Related]
5. [Current role of metformin in treatment of diabetes mellitus type 2].
Janssen JA
Ned Tijdschr Geneeskd; 2000 Sep; 144(40):1900-2. PubMed ID: 11045135
[TBL] [Abstract][Full Text] [Related]
6. Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study.
Nathan DM
Lancet; 1998 Sep; 352(9131):832-3. PubMed ID: 9742972
[No Abstract] [Full Text] [Related]
7. [United Kingdom Prospective Diabetes Study (UKPDS): 10 years later].
Scheen AJ; Paquot N; Lefebvre PJ
Rev Med Liege; 2008 Oct; 63(10):624-9. PubMed ID: 19009971
[TBL] [Abstract][Full Text] [Related]
8. [Metformin and type 2 diabetes: the UKPDS experience].
Leverve XM
Journ Annu Diabetol Hotel Dieu; 2007; ():5-11. PubMed ID: 18610755
[No Abstract] [Full Text] [Related]
9. [Should the occurrence of a first coronary event change the management of diabetes?].
Timsit J; Dubois-Laforgue D
Arch Mal Coeur Vaiss; 2000 Dec; 93 Spec No 4():39-44. PubMed ID: 11296461
[TBL] [Abstract][Full Text] [Related]
10. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
André P
Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
[No Abstract] [Full Text] [Related]
11. [Drug treatment of type 2 diabetes].
Plank J; Bock GM
Wien Med Wochenschr; 2003; 153(21-22):452-8. PubMed ID: 14679886
[TBL] [Abstract][Full Text] [Related]
12. The continuing legacy of the United Kingdom Prospective Diabetes Study.
Davis TM; Colagiuri S;
Med J Aust; 2004 Feb; 180(3):104-5. PubMed ID: 14748669
[No Abstract] [Full Text] [Related]
13. Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study.
McCormack J; Greenhalgh T
BMJ; 2000 Jun; 320(7251):1720-3. PubMed ID: 10864554
[No Abstract] [Full Text] [Related]
14. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
15. [Not Available].
Steurer J
Praxis (Bern 1994); 2016 Sep; 105(20):1221-1222. PubMed ID: 27705192
[No Abstract] [Full Text] [Related]
16. Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.
Miles JM; Leiter L; Hollander P; Wadden T; Anderson JW; Doyle M; Foreyt J; Aronne L; Klein S
Diabetes Care; 2002 Jul; 25(7):1123-8. PubMed ID: 12087008
[TBL] [Abstract][Full Text] [Related]
17. Metformin as first choice in oral diabetes treatment: the UKPDS experience.
Holman R
Journ Annu Diabetol Hotel Dieu; 2007; ():13-20. PubMed ID: 18613325
[TBL] [Abstract][Full Text] [Related]
18. [Metformin in the UKPDS study. Metabolic and vascular results].
Basin C; Isnard F
Journ Annu Diabetol Hotel Dieu; 1999; ():243-61. PubMed ID: 10732421
[No Abstract] [Full Text] [Related]
19. Implications of the United Kingdom Prospective Diabetes Study.
American Diabetes Association
Diabetes Care; 2000 Jan; 23 Suppl 1():S27-31. PubMed ID: 12017673
[No Abstract] [Full Text] [Related]
20. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
